| pubmed-article:16643817 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16643817 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:16643817 | lifeskim:mentions | umls-concept:C0015934 | lld:lifeskim |
| pubmed-article:16643817 | lifeskim:mentions | umls-concept:C1858460 | lld:lifeskim |
| pubmed-article:16643817 | lifeskim:mentions | umls-concept:C0078058 | lld:lifeskim |
| pubmed-article:16643817 | lifeskim:mentions | umls-concept:C0226378 | lld:lifeskim |
| pubmed-article:16643817 | lifeskim:mentions | umls-concept:C0378516 | lld:lifeskim |
| pubmed-article:16643817 | lifeskim:mentions | umls-concept:C1749467 | lld:lifeskim |
| pubmed-article:16643817 | lifeskim:mentions | umls-concept:C0683149 | lld:lifeskim |
| pubmed-article:16643817 | lifeskim:mentions | umls-concept:C0554756 | lld:lifeskim |
| pubmed-article:16643817 | lifeskim:mentions | umls-concept:C0205161 | lld:lifeskim |
| pubmed-article:16643817 | lifeskim:mentions | umls-concept:C1171892 | lld:lifeskim |
| pubmed-article:16643817 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:16643817 | pubmed:dateCreated | 2006-11-29 | lld:pubmed |
| pubmed-article:16643817 | pubmed:abstractText | This study was undertaken to determine whether maternal serum concentration of the angiogenic factor vascular endothelial growth factor (VEGF) and its circulating antagonist, soluble fms-like tyrosine kinase 1 (sFlt-1), which have been implicated in the pathogenesis of preeclampsia (PE), are altered in pregnancies that subsequently develop PE and in those with established fetal growth restriction (FGR). | lld:pubmed |
| pubmed-article:16643817 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16643817 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16643817 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16643817 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16643817 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16643817 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16643817 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16643817 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16643817 | pubmed:issn | 1097-6868 | lld:pubmed |
| pubmed-article:16643817 | pubmed:author | pubmed-author:SavvidouMakri... | lld:pubmed |
| pubmed-article:16643817 | pubmed:author | pubmed-author:NicolaidesKyp... | lld:pubmed |
| pubmed-article:16643817 | pubmed:author | pubmed-author:HingoraniAroo... | lld:pubmed |
| pubmed-article:16643817 | pubmed:author | pubmed-author:YuChristina... | lld:pubmed |
| pubmed-article:16643817 | pubmed:author | pubmed-author:HarlandLisa... | lld:pubmed |
| pubmed-article:16643817 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16643817 | pubmed:volume | 195 | lld:pubmed |
| pubmed-article:16643817 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16643817 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16643817 | pubmed:pagination | 1668-73 | lld:pubmed |
| pubmed-article:16643817 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:meshHeading | pubmed-meshheading:16643817... | lld:pubmed |
| pubmed-article:16643817 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16643817 | pubmed:articleTitle | Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. | lld:pubmed |
| pubmed-article:16643817 | pubmed:affiliation | Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, United Kingdom. | lld:pubmed |
| pubmed-article:16643817 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16643817 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16643817 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16643817 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16643817 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16643817 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16643817 | lld:pubmed |
